Kerrisdale Advisers’s CVS Health CVS Stock Holding History

Kerrisdale Advisers’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-65,080	Closed	-$3.86M	–	66
2020 Q1	$3.86M	Buy	+65,080	New	+$4.34M	0.74%	30

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Kerrisdale Advisers's CVS Position: Q2 2020 in Review

Kerrisdale Advisers sold out of CVS Health (CVS) in Q2 2020, closing a stake of 65,080 shares — an estimated $3.86M sold.

Kerrisdale Advisers first reported a position in CVS in Q1 2020 and held it in 1 quarter. The position peaked at $3.86M in Q1 2020. 1,864 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

Kerrisdale Advisers reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
Kerrisdale Advisers sold 65,080 CVS Health shares in Q2 2020, an estimated $3.86M.
Kerrisdale Advisers first reported a position in CVS Health in Q1 2020 and held it in 1 quarter.
Kerrisdale Advisers's CVS Health position peaked at $3.86M in Q1 2020.
1,864 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on Kerrisdale Advisers's 13F filing for Q2 2020, filed 14 Aug 2020.